LobbyingApotex lobbying by quarter
Apotex's latest lobbying report covers Q2 2026, at $810K. The four quarters Q4 2025–Q3 2026 total $2M. Its first report covers Q4 2022; the issues it reports most are Manufacturing and Health Issues.
Apotex
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $2M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $570K | 2 |
| Q1 2023 | $190K | 2 |
| Q2 2023 | $170K | 2 |
| Q3 2023 | $170K | 2 |
| Q4 2023 | $580K | 2 |
| Q1 2024 | $210K | 3 |
| Q2 2024 | $230K | 3 |
| Q3 2024 | $230K | 3 |
| Q4 2024 | $330K | 4 |
| Q1 2025 | $1M | 4 |
| Q2 2025 | $490K | 4 |
| Q3 2025 | $500K | 4 |
| Q4 2025 | $410K | 4 |
| Q1 2026 | $800K | 3 |
| Q2 2026 | $810K | 3 |
| Q3 2026 | $0 | 0 |
By issue
- Manufacturing$2.6M · 28 reports
- Health issues$2.4M · 27 reports
- Tariffs$710K · 10 reports
- Copyright, patent and trademark$425.8K · 2 reports
- Trade$425.8K · 2 reports
- Budget and appropriations$66.7K · 2 reports
- Defense$36.7K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE37 reports
- HOUSE OF REPRESENTATIVES32 reports
- Executive Office of the President (EOP)7 reports
- Natl Economic Council (NEC)6 reports
- U.S. Trade Representative (USTR)6 reports
- Health & Human Services, Dept of (HHS)5 reports
- Office of Management & Budget (OMB)4 reports
- White House Office4 reports
- Commerce, Dept of (DOC)2 reports
- Natl Security Council (NSC)2 reports
- Bureau of Industry and Security (BIS)1 reports
- Centers For Medicare and Medicaid Services (CMS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseApotex | $5.3M | 15 quarters |
| Government Counsel | $490K | 15 quarters |
| Ballard Partners | $480K | 5 quarters |
| Kountoupes Denham Carr & Reid | $470K | 10 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| HENRY W MENN iii | Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner. | Q2 2026 |
| HUNTER MORGEN | Policy Advisor, Office of Policy Planning, U.S. State Dept. (2017); Deputy Director, Office of Trade & Manufacturing Policy, WH (2017-2018); Special Assistant to the President, Office of the Senior Advisor for Policy, WH (2018-2020) | Q4 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Government Counsel | $30K |
| 07/20for Q2 | In-house | $730K |
| 07/08for Q2 | Kountoupes Denham Carr & Reid | $50K |
| 04/20for Q1 | In-house | $730K |
| 04/17for Q1 | Government Counsel | $20K |
| 04/09for Q1 | Kountoupes Denham Carr & Reid | $50K |
| 01/19for Q4 2025 | Ballard Partners | $80K |
| 01/19for Q4 2025 | Government Counsel | $20K |
| 01/19for Q4 2025 | In-house | $260K |
| 01/14for Q4 2025 | Kountoupes Denham Carr & Reid | $50K |
| 25/10/17for Q3 2025 | In-house | $310K |
| 25/10/14for Q3 2025 | Ballard Partners | $120K |
| 25/10/09for Q3 2025 | Kountoupes Denham Carr & Reid | $50K |
| 25/10/02for Q3 2025 | Government Counsel | $20K |
| 25/07/18for Q2 2025 | In-house | $300K |
| 25/07/17for Q2 2025 | Kountoupes Denham Carr & Reid | $50K |
| 25/07/14for Q2 2025 | Ballard Partners | $120K |
| 25/07/09for Q2 2025 | Government Counsel | $20K |
| 25/04/21for Q1 2025 | In-house | $810K |
| 25/04/19for Q1 2025 | Ballard Partners | $120K |